4//SEC Filing
MERZOUKI ABDERRAZZAK 4
Accession 0001128732-19-000032
CIK 0001402328other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 9:19 AM ET
Size
5.1 KB
Accession
0001128732-19-000032
Insider Transaction Report
Form 4
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2019-09-02$0.00/sh+13,000,000$13,000→ 18,850,000 total
Footnotes (1)
- [F1]Issuer effectuated a reverse stock split effective February 1, 2019 wherein one share of Common Stock of the Issuer was issued for each 20 shares of Common Stock issued and oustanding resulting in Reporting Person owning 5,850,000 shares of Common Stock of the Issuer as of that date.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001636418
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 9:19 AM ET
- Size
- 5.1 KB